Skip to main content
TipRanks
Go Ultimate75% OFF

Jasper Therapeutics (JSPR) Income Statement

1,073 Followers

Jasper Therapeutics Income Statement

Last quarter (Q3 2026), Jasper Therapeutics's total revenue was $8.00M. In Q3, Jasper Therapeutics's net income was $0.00. See Jasper Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ -1.06M$ 0.00$ 0.00$ 0.00$ 0.00
$ 79.46M$ 76.24M$ 68.86M$ 51.20M$ 36.83M
Depreciation and Amortization$ 1.06M$ 1.37M$ 1.11M$ 975.00K$ 377.00K
$ -74.75M$ -69.90M$ -63.36M$ -36.71M$ -30.26M
$ -80.52M$ -76.24M$ -68.86M$ -51.20M$ -36.83M
$ 4.72M$ 4.97M$ 4.40M$ 13.51M$ 6.20M
$ -75.80M$ -71.27M$ -64.47M$ -37.69M$ -30.64M
$ -75.80M$ -71.27M$ -64.47M$ -37.69M$ -30.64M
Per Share Metrics
Basic EPS$ -118.50$ -146.70$ -185.40$ -309.90$ -806.70
Diluted EPS$ -118.50$ -146.70$ -185.40$ -309.90$ -806.70
Weighted Average Shares Outstanding638.94K486.13K347.97K121.60K37.97K
Weighted Average Shares Outstanding (Diluted)638.94K486.16K347.97K121.61K37.98K

Currency in USD

Jasper Therapeutics Earnings and Revenue History

-90M-60M-30M00 %0.4 %0.8 %1.2 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin